pyridinolcarbamate has been researched along with Cardiovascular Stroke in 2 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liusov, VA | 1 |
| Belousov, IuB | 1 |
| Ianushkevichus, Z | 1 |
| Bluzhas, I | 1 |
| Misiunene, N | 1 |
| Markunene, A | 1 |
| Gribauskas, P | 1 |
2 other studies available for pyridinolcarbamate and Cardiovascular Stroke
| Article | Year |
|---|---|
[Antithrombotic therapy of ischemic heart disease].
Topics: Anticoagulants; Blood Coagulation; Coronary Disease; Fibrinolytic Agents; Heparin; Humans; Hypolipid | 1974 |
[Certain clinical and biochemical results of pyridinolcarbamate treatment of patients with ischemic heart disease].
Topics: Adult; Aged; Arteriosclerosis; Hemostasis; Humans; Hypolipidemic Agents; Male; Myocardial Infarction | 1973 |